Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 07/01/2023 - 12/31/2023

Lobbyist name	Jennifer Herz
Business name	Boehringer Ingelheim Pharmaceuticals, Inc.
Address	900 Ridgebury Road
City, state, zip code	Ridgefield, CT 06877
Country	US
Agent type	Both
Phone	860-970-4404

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Boehringer Ingelheim Pharmaceuticals, Inc.

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	943	An Act to reduce co-pays for people with chronic conditions	Support	$115.32	N/A
House Bill	1247	An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth	Neutral	$115.32	N/A
Senate Bill	714	An Act relative to pharmaceutical gag clauses	Support	$115.32	N/A
House Bill	1176	An Act relative to promoting comprehensive transparency in the pharmaceutical industry	Neutral	$115.32	N/A
Senate Bill	609	An Act relative to consumer deductibles	Neutral	$115.32	N/A
Senate Bill	2595	Communication from the Executive of Health Human Services	Neutral	$115.32	N/A
House Bill	982	An Act relative to non-medical switching	Support	$115.32	N/A
Senate Bill	479	An Act protecting pollinators by eliminating harmful products	Neutral	$115.32	N/A
Senate Bill	1126	An Act promoting pet safety aka Crawford's Law	Neutral	$115.32	N/A
House Bill	959	An Act prohibiting discrimination against 340b drug discount program participants	Neutral	$115.32	N/A
House Bill	2249	An Act relative to the availability of prescription medication during an emergency	Neutral	$115.32	N/A
Senate Bill	776	An Act limiting out of pocket expenses	Neutral	$115.32	N/A
House Bill	1147	An Act ensuring access to specialty medications	Neutral	$115.32	N/A
Senate Bill	603	An Act promoting consumer choice in health care	Neutral	$115.32	N/A
Senate Bill	1419	An Act to prevent undue influence on prescriber behavior	Neutral	$115.32	N/A
House Bill	937	An Act relative to transparency of consumer health insurance rights	Neutral	$115.32	N/A
House Bill	1246	An Act relative to drug prices paid by carriers	Neutral	$115.32	N/A
Senate Bill	704	An Act prohibiting discrimination against 340b drug discount program participants	Neutral	$115.32	N/A
House Bill	1201	An Act to promote transparency in prescription drug prices	Neutral	$115.32	N/A
Senate Bill	612	An Act relative to promoting healthcare access and affordability for patients	Neutral	$115.32	N/A
House Bill	978	An Act relative to promoting healthcare access and affordability for patients	Support	$115.32	N/A
House Bill	3587	An Act to ensure access to prescription medications	Neutral	$115.32	N/A
Senate Bill	783	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Neutral	$115.32	N/A
House Bill	1055	An Act relative to pharmaceutical gag clauses	Support	$115.32	N/A
Senate Bill	602	An Act relative to transparency of consumer health insurance rights	Neutral	$115.32	N/A
Senate Bill	1418	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Neutral	$115.32	N/A
House Bill	863	An Act relative to proper disposal of products containing PFAS	Neutral	$115.32	N/A
House Bill	1215	An Act relative to pharmacy benefit managers	Neutral	$115.32	N/A
Senate Bill	656	An Act to reduce the cost of pharmacy benefits	Neutral	$115.32	N/A
House Bill	945	An Act to ensure prescription drug cost transparency and affordability	Neutral	$115.32	N/A
House Bill	1718	An Act relative to the humane protection of animals	Neutral	$115.32	N/A
Senate Bill	732	An Act relative to promoting comprehensive transparency in the pharmaceutical industry	Neutral	$115.32	N/A
House Bill	999	An Act empowering health care consumers	Neutral	$115.32	N/A
Senate Bill	580	An Act further protecting research animals	Neutral	$115.32	N/A
Senate Bill	1356	An Act to protect Massachusetts public health from PFAS	Neutral	$115.32	N/A
House Bill	953	An Act relative to consumer deductibles	Support	$115.32	N/A
House Bill	2197	An Act to protect Massachusetts public health from PFAS	Neutral	$115.32	N/A
Senate Bill	767	An Act to define modest meals and refreshments in prescriber education settings	Neutral	$115.32	N/A
House Bill	1206	An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth	Neutral	$115.32	N/A
Senate Bill	612	An Act relative to promoting healthcare access and affordability for patients	Neutral	$115.32	N/A
House Bill	850	An Act concerning the use of animals in product testing	Neutral	$115.32	N/A
House Bill	1208	An Act establishing a state-wide drug repository program	Neutral	$115.32	N/A
Senate Bill	630	An Act ensuring access to specialty medications	Neutral	$115.32	N/A
House Bill	1150	An Act to ensure access to generic medication	Neutral	$115.32	N/A
Senate Bill	605	An Act empowering health care consumers	Neutral	$115.32	N/A
Senate Bill	1862	An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing	Neutral	$115.32	N/A
			Total amount	$5,304.72

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.

Close this page

Connect with Us